Adjuvant therapy of breast cancer has evolved over the past 15 years from an interesting clinical experiment to the standard of care for many patients. The toxicities of different treatments vary from those with minimal side effects, such as tamoxifen, to those with potentially lifethreatening side
โฆ LIBER โฆ
Prognostic factors: Determination and role in design of clinical trials
โ Scribed by Stanley, Kenneth E.
- Book ID
- 122746167
- Publisher
- Elsevier Science
- Year
- 1980
- Tongue
- English
- Weight
- 76 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0197-2456
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Prognostic factors observed in current c
โ
F. Andrew Dorr
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 586 KB
The use of prognostic factors in clinica
โ
Harland N. Sather
๐
Article
๐
1986
๐
John Wiley and Sons
๐
English
โ 735 KB
Incorporation of Prognostic and Predicti
โ
Derek R. Johnson, Evanthia Galanis
๐
Article
๐
2012
๐
Current Science Inc.
๐
English
โ 148 KB
Importance of prognostic factors in the
โ
Armitage, Peter
๐
Article
๐
1981
๐
Elsevier Science
๐
English
โ 408 KB
Role of placebo factors in clinical tria
โ
Roland Staud; Donald D. Price
๐
Article
๐
2008
๐
Elsevier Science
๐
English
โ 63 KB
Prognostic factors for survival in patie
โ
Linda Janisch; Rosemarie Mick; Richard L. Schilsky; Nicholas J. Vogelzang; Sheil
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 720 KB
Background. Patients with advanced or metastatic cancer treated in Phase I clinical trials are considered to have a poor prognosis. Survival from first treatment in a Phase I trial was determined for 349 patients. Univariate and multivariate survival analyses were performed to determine whether pote